SM
COGT icon

Sabby Management’s Cogent Biosciences COGT Stock Holding History

Sabby Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-12,731
Closed -$133K – 100
2019
Q2 		$133K Sell
12,731
-38,859
-75% -$517K 0.17% 64
2019
Q1 		$906K Sell
51,590
-60,114
-54% -$1.03M 0.44% 21
2018
Q4 		$1.97M Sell
111,704
-23,651
-17% -$700K 0.43% 28
2018
Q3 		$5.58M Sell
135,355
-9,971
-7% -$562K 0.71% 23
2018
Q2 		$8.34M Sell
145,326
-65,637
-31% -$3.16M 1.29% 19
2018
Q1 		$9.38M Buy
+210,963
New +$9.38M 1.12% 17

Other funds holding COGT

AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sabby Management's COGT Position: Q3 2019 in Review

Sabby Management sold out of Cogent Biosciences (COGT) in Q3 2019, closing a stake of 12,731 shares — an estimated $133K sold.

Sabby Management first reported a position in COGT in Q1 2018 and held it in 6 quarters. The position peaked at $9.38M in Q1 2018. 36 funds tracked by Wall St. Rank hold COGT as of Q3 2019.

  • Sabby Management reported no remaining Cogent Biosciences position as of Q3 2019 after selling out during the quarter.
  • Sabby Management sold 12,731 Cogent Biosciences shares in Q3 2019, an estimated $133K.
  • Sabby Management first reported a position in Cogent Biosciences in Q1 2018 and held it in 6 quarters.
  • Sabby Management's Cogent Biosciences position peaked at $9.38M in Q1 2018.
  • 36 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2019.

Based on Sabby Management's 13F filing for Q3 2019, filed 15 Nov 2019.